Glenview Capital Management - Q1 2023 holdings

$4.56 Billion is the total value of Glenview Capital Management's 54 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 54.7% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$491,022,366
+78.6%
1,199,400
+66.8%
10.77%
+76.9%
CI BuyTHE CIGNA GROUP$472,892,250
-22.4%
1,850,633
+0.6%
10.38%
-23.2%
THC SellTENET HEALTHCARE CORP$431,838,950
-0.5%
7,267,569
-18.3%
9.48%
-1.5%
FISV SellFISERV INC$243,104,698
-4.7%
2,150,798
-14.8%
5.33%
-5.6%
GPN SellGLOBAL PMTS INC$236,176,872
-0.6%
2,244,174
-6.2%
5.18%
-1.5%
DXC SellDXC TECHNOLOGY CO$228,944,422
-11.0%
8,957,137
-7.7%
5.02%
-11.8%
MCK SellMCKESSON CORP$227,849,569
-6.6%
639,937
-1.6%
5.00%
-7.6%
VVV BuyVALVOLINE INC$132,875,038
+16.5%
3,802,949
+8.9%
2.92%
+15.4%
USFD SellUS FOODS HLDG CORP$132,681,572
+1.5%
3,591,813
-6.6%
2.91%
+0.5%
ALIT BuyALIGHT INC$130,271,683
+99.1%
14,144,591
+80.7%
2.86%
+97.1%
HCA BuyHCA HEALTHCARE INC$119,243,215
+12.9%
452,227
+2.8%
2.62%
+11.8%
UHS SellUNIVERSAL HLTH SVCS INCcl b$109,573,291
-14.1%
862,103
-4.8%
2.40%
-15.0%
CLVT BuyCLARIVATE PLC$109,192,207
+29.9%
11,628,563
+15.4%
2.40%
+28.7%
APTV BuyAPTIV PLC$104,666,651
+22.0%
932,941
+1.3%
2.30%
+20.8%
CTVA BuyCORTEVA INC$98,860,634
+147.5%
1,639,208
+141.2%
2.17%
+145.1%
FMC BuyFMC CORP$98,029,599
+8.8%
802,666
+11.2%
2.15%
+7.8%
MYGN BuyMYRIAD GENETICS INC$97,452,452
+116.8%
4,195,112
+35.4%
2.14%
+114.7%
UBER SellUBER TECHNOLOGIES INC$94,391,981
-4.7%
2,977,665
-25.7%
2.07%
-5.6%
DD BuyDUPONT DE NEMOURS INC$87,348,109
+11.2%
1,217,056
+6.3%
1.92%
+10.1%
ATVI SellACTIVISION BLIZZARD INC$71,781,081
-3.4%
838,662
-13.6%
1.58%
-4.3%
CCEP SellCOCA-COLA EUROPACIFIC PARTNE$71,201,545
-37.8%
1,202,932
-41.9%
1.56%
-38.4%
LII BuyLENNOX INTL INC$59,761,671
+41.6%
237,829
+34.8%
1.31%
+40.2%
ESI SellELEMENT SOLUTIONS INC$58,399,793
+3.6%
3,024,329
-2.4%
1.28%
+2.6%
BKD BuyBROOKDALE SR LIVING INC$55,001,785
+45.5%
18,644,673
+34.7%
1.21%
+44.2%
NSC BuyNORFOLK SOUTHN CORP$54,156,460
-3.4%
255,455
+12.2%
1.19%
-4.3%
AMZN NewAMAZON COM INC$46,967,822454,718
+100.0%
1.03%
ABC BuyAMERISOURCEBERGEN CORP$44,449,418
+6204.0%
277,618
+6424.5%
0.98%
+5993.8%
FLEX SellFLEX LTDord$44,233,274
-49.1%
1,922,350
-52.5%
0.97%
-49.6%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$41,184,977
+36.0%
403,063
+17.2%
0.90%
+34.7%
AVTR NewAVANTOR INC$39,379,5921,862,800
+100.0%
0.86%
FDX NewFEDEX CORP$37,148,590162,583
+100.0%
0.82%
EXPE SellEXPEDIA GROUP INC$37,166,177
-15.9%
383,038
-24.1%
0.82%
-16.8%
GOOGL SellALPHABET INCcap stk cl a$32,850,772
+5.2%
316,695
-10.5%
0.72%
+4.2%
DVA NewDAVITA INC$22,400,554276,175
+100.0%
0.49%
KNX NewKNIGHT-SWIFT TRANSN HLDGS INcl a$21,299,541376,450
+100.0%
0.47%
BuyEVOLV TECHNOLOGIES HLDNGS IN$19,708,647
+27.3%
6,316,874
+5.6%
0.43%
+25.9%
MTCH NewMATCH GROUP INC NEW$18,230,874474,886
+100.0%
0.40%
NewBROOKDALE SR LIVING INCnote 2.000%10/1$18,194,07825,450,000
+100.0%
0.40%
UNH NewUNITEDHEALTH GROUP INC$17,351,61436,716
+100.0%
0.38%
BFLY BuyBUTTERFLY NETWORK INC$15,102,982
+12.3%
8,033,501
+47.0%
0.33%
+11.1%
UNP NewUNION PAC CORP$12,579,55562,504
+100.0%
0.28%
LH NewLABORATORY CORP AMER HLDGS$11,563,22750,402
+100.0%
0.25%
WLTW SellWILLIS TOWERS WATSON PLC LTD$10,815,198
-69.3%
46,541
-67.7%
0.24%
-69.7%
CAH NewCARDINAL HEALTH INC$10,647,916141,032
+100.0%
0.23%
SABR BuySABRE CORP$9,439,707
+34.4%
2,200,398
+93.6%
0.21%
+32.7%
DMRC SellDIGIMARC CORP NEW$8,537,866
+4.9%
434,497
-1.3%
0.19%
+3.9%
QSI SellQUANTUM SI INC$7,420,142
-4.6%
4,215,990
-0.8%
0.16%
-5.2%
ANTM NewELEVANCE HEALTH INC$5,456,56511,867
+100.0%
0.12%
BLI BuyPHENOMEX INC$4,426,923
-36.7%
3,816,313
+46.2%
0.10%
-37.4%
DNB SellDUN & BRADSTREET HLDGS INC$1,812,351
-83.2%
154,374
-82.4%
0.04%
-83.2%
BuyRAPID MICRO BIOSYSTEMS INC$1,071,957
+17.1%
818,288
+1.0%
0.02%
+20.0%
CANO NewCANO HEALTH INC$864,616950,127
+100.0%
0.02%
BFLYWS NewBUTTERFLY NETWORK INC*w exp 02/12/202$455,9181,713,333
+100.0%
0.01%
NewDOMA HOLDINGS INC$203,750500,000
+100.0%
0.00%
FTCH ExitFARFETCH LTDord sh cl a$0-618,916
-100.0%
-0.06%
ExitISOPLEXIS CORP$0-1,970,000
-100.0%
-0.07%
NEWR ExitNEW RELIC INC$0-160,683
-100.0%
-0.20%
BHC ExitBAUSCH HEALTH COS INC$0-1,500,000
-100.0%
-0.21%
SPLK ExitSPLUNK INC$0-146,220
-100.0%
-0.28%
TPX ExitTEMPUR SEALY INTL INC$0-391,700
-100.0%
-0.30%
PYPL ExitPAYPAL HLDGS INC$0-250,000
-100.0%
-0.39%
URI ExitUNITED RENTALS INC$0-77,860
-100.0%
-0.61%
LVS ExitLAS VEGAS SANDS CORP$0-765,576
-100.0%
-0.82%
BKNG ExitBOOKING HOLDINGS INC$0-18,589
-100.0%
-0.83%
ZI ExitZOOMINFO TECHNOLOGIES INC$0-1,746,519
-100.0%
-1.16%
FB ExitMETA PLATFORMS INCcl a$0-526,142
-100.0%
-1.40%
CI ExitCIGNA CORP NEWcall$0-200,000
-100.0%
-1.47%
BAX ExitBAXTER INTL INC$0-2,009,973
-100.0%
-2.27%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

About Glenview Capital Management

Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.

Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.

Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.

Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENET HEALTHCARE CORP40Q1 202316.7%
HCA HOLDINGS INC40Q1 20239.1%
MCKESSON CORP38Q1 20238.2%
FLEXTRONICS INTL LTD37Q1 20234.5%
BROOKDALE SR LIVING INC36Q1 20232.1%
MERITOR INC36Q1 20223.0%
FMC CORP33Q1 20236.4%
UNIVERSAL HLTH SVCS INC32Q1 20232.8%
HUMANA INC31Q4 202112.1%
ENDO INTL PLC30Q1 20222.8%

View Glenview Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Glenview Capital Management Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MYRIAD GENETICS INCMarch 01, 20234,312,1315.3%
Brookdale Senior Living Inc.February 14, 202313,844,6737.4%
Butterfly Network, Inc.February 14, 20239,746,8345.5%
Quantum-Si IncFebruary 14, 20234,249,9563.6%
TENET HEALTHCARE CORPFebruary 14, 20238,896,1118.2%
MERITOR, INC.February 22, 20223,544,3335.0%
ATI Physical Therapy, Inc.Sold outFebruary 14, 202200.0%
Evolv Technologies Holdings, Inc.February 14, 2022749,4610.5%
Velocity Acquisition Corp.Sold outFebruary 14, 202200.0%
Bausch Health Companies Inc.December 13, 202117,078,6574.8%

View Glenview Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-05-15
SC 13G2023-03-01
SC 13D/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-16

View Glenview Capital Management's complete filings history.

Compare quarters

Export Glenview Capital Management's holdings